The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures
Siméon A, Emonard H, Hornebeck W, Maquart FX
Life Sciences (2000)
GHK-Cu raised MMP-2 levels, MMP-2 mRNA, and TIMP-1/TIMP-2 secretion in fibroblast cultures — and the effect was driven by the copper ion rather than the bare tripeptide. The second-pillar mechanistic primary establishing GHK-Cu as a coordinated matrix-remodelling signal rather than a one-way collagen-deposition driver.
This 2000 Life Sciences paper from Maquart's Reims group is the second-pillar primary mechanistic source for the modern GHK-Cu story, complementing the 1988 collagen-synthesis paper. Where Maquart 1988 showed that GHK-Cu stimulates collagen biosynthesis, this paper shows that the same molecule simultaneously activates the matrix-remodelling enzymes that prevent that newly synthesized collagen from accumulating into a fibrotic scar.
Siméon and colleagues applied GHK-Cu to cultured dermal fibroblasts and measured matrix metalloproteinase-2 (MMP-2), MMP-2 mRNA, and the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in conditioned media. GHK-Cu significantly increased MMP-2 levels in the conditioned media; the increase was reflected at the mRNA level, indicating transcriptional regulation rather than only secretion or activation. TIMP-1 and TIMP-2 secretion were also enhanced, meaning the MMP-2 upregulation was paired with proportional inhibitor expression — the hallmark of a coordinated remodelling program rather than uncontrolled proteolysis.
A key mechanistic finding: the MMP-2-stimulating activity was driven by the copper ion itself rather than the bare tripeptide. This positions copper-loading as load-bearing for the matrix-remodelling effects, separate from any copper-independent activity the tripeptide alone might have. The authors concluded that GHK-Cu functions not merely as a connective-tissue activator but as a modulator of extracellular matrix remodelling — synthesis and controlled turnover acting in coordination.
This is an in-vitro fibroblast-culture study — the cells are dermal fibroblasts, and the readout is conditioned-media protein and mRNA, not tissue-level matrix architecture. The MMP-2 upregulation is documented; whether the in-vivo balance between MMP-2 activation and TIMP-1/TIMP-2 inhibition produces net matrix turnover, net deposition, or net controlled remodelling depends on tissue context not modelled in cell culture.
The copper-dependence finding is mechanistically important but should be interpreted carefully — the experimental designs comparing GHK alone vs GHK-Cu have varied across the literature in their copper-loading kinetics, and the abstract does not provide the full comparator details. Readers should consult the full paper for the exact GHK / Cu²⁺ / GHK-Cu comparison protocol before downstream-citing the "copper is the active component" claim with confidence.
The 2000 paper is now a quarter-century old; the broader MMP/TIMP literature has shifted considerably since then, and the specific transcriptional pathways linking GHK-Cu to MMP-2 expression have been only partially characterised in subsequent work.
07·Member discussion
No member discussion yet.
Member-only conversation lives here — cycle notes, practitioner commentary, pattern-matching. Be the first paying member to start the thread.